EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

DHA Ameliorates Alzheimer’s Disease by Attenuating Microglial Pyroptosis via Regulation of the HOXA9-NLRP3 Pathway

Jia-Li Xie, Xiao-Hui Hu, Chun-Ling Wu, Qi Jin, Jian-Ping Pan

Frontiers in Bioscience-Landmark · 2026-02-28 · 31 (3)

DOI: 10.31083/fbl46572 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, published online on 2026-02-28. Written by Jia-Li Xie and 4 co-authors. Institution: Department of Basic Medicine, Gannan Health Vocational College, 341000 Ganzhou, Jiangxi, China. Major MEDLINE topics: NLR Family, Pyrin Domain-Containing 3 Protein, Docosahexaenoic Acids, Alzheimer Disease, Pyroptosis. 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Jiangxi Provincial Natural Science Foundation General Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Alzheimer’s disease (AD) involves a progressive deterioration of cognitive abilities, memory loss, and persistent brain inflammation. Emerging evidence indicates that pyroptosis mediated by the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, contributes significantly to AD development. Docosahexaenoic acid (DHA) has demonstrated neuroprotective properties; however, the precise mechanisms by which it modulates pyroptosis in AD have yet to remained incompletely elucidated.

Objective

To explore the role of DHA in modulating microglial pyroptosis via the HOXA9-NLRP3 pathway in an AD model.

Methods

Effects of DHA on Aβ25–35-induced pyroptosis were assessed in human microglial clone 3 (HMC3) human microglial cells using CCK-8, western blotting, immunofluorescence, and Enzyme-linked Immunosorbent Assay (ELISA) assays. The role of homeobox A9 (HOXA9) in pyroptosis regulation was evaluated through overexpression and knockdown experiments. Dual-luciferase reporter assays together with chromatin immunoprecipitation (ChIP) were used to verify the interaction of HOXA9 to NLRP3 promoter. Amyloid precursor protein / Presenilin-1 double-transgenic (APP/PS1) transgenic AD mice underwent DHA treatment in vivo, and cognitive performance was assessed using the Morris water maze paradigm. Expression of HOXA9, NLRP3, and pyroptosis-related proteins were analyzed by Quantitative Real-time Reverse Transcription PCR (qRT-PCR), Western blotting, and immunofluorescence.

Results

DHA treatment significantly reduced Aβ25–35-induced microglial pyroptosis, as indicated by decreased levels of p30-Gasdermin D (GSDMD), cleaved-caspase-1, IL-1β, and IL-18. HOXA9 overexpression reversed the protective effects of DHA, whereas NLRP3 inhibition by MCC950 enhanced DHA inhibition of pyroptosis. Dual-luciferase and ChIP assays confirmed that HOXA9 directly regulates NLRP3 transcription. In APP/PS1 mice, DHA administration enhanced cognitive performance while simultaneously decreasing the expression of pyroptosis-related markers and inflammatory mediators in brain. Inhibition of NLRP3 signaling by MCC950 further strengthened the neuroprotective actions of DHA.

Conclusion

DHA ameliorates AD-related cognitive decline and reduces microglial pyroptosis through suppressing the HOXA9-NLRP3 axis. These results offer novel insights into the molecular basis of DHA-mediated neuroprotection and highlight potential therapeutic targets for AD.

Subjects

MeSH terms (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinDocosahexaenoic AcidsAlzheimer DiseasePyroptosisMicrogliaHomeodomain ProteinsAnimalsHumansMiceSignal TransductionMice, TransgenicMaleDisease Models, AnimalMice, Inbred C57BL

Author keywords

Alzheimer’s DiseaseNLR family pyrin domain-containing 3 proteindocosahexaenoic acidhomeobox genesmicroglianeuroinflammationpyroptosis

Substances

NLR Family, Pyrin Domain-Containing 3 ProteinDocosahexaenoic AcidsHomeodomain ProteinsNlrp3 protein, mouseNLRP3 protein, human

Authors and institutions

  • Department of Basic Medicine, Gannan Health Vocational College, 341000 Ganzhou, Jiangxi, China.
  • College of Pharmacy, Gannan Medical University, 341000 Ganzhou, Jiangxi, China.
  • Department of Pharmacy, Gannan Health Vocational College, 341000 Ganzhou, Jiangxi, China.

Funding

  • Jiangxi Provincial Natural Science Foundation General Project

Cite

APA

Xie, J. L., Hu, X. H., Wu, C. L., Jin, Q., & Pan, J. P. (2026). DHA Ameliorates Alzheimer’s Disease by Attenuating Microglial Pyroptosis via Regulation of the HOXA9-NLRP3 Pathway. Frontiers in Bioscience-Landmark, 31(3). https://doi.org/10.31083/fbl46572

Vancouver

Xie JL, Hu XH, Wu CL, Jin Q, Pan JP. DHA Ameliorates Alzheimer’s Disease by Attenuating Microglial Pyroptosis via Regulation of the HOXA9-NLRP3 Pathway. Frontiers in Bioscience-Landmark. 2026;31(3). doi:10.31083/fbl46572

BibTeX
@article{Xie2026,
  author = {Xie, Jia-Li and Hu, Xiao-Hui and Wu, Chun-Ling and Jin, Qi and Pan, Jian-Ping},
  title = {DHA Ameliorates Alzheimer’s Disease by Attenuating Microglial Pyroptosis via Regulation of the HOXA9-NLRP3 Pathway},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {3},
  doi = {10.31083/fbl46572}
}
Start for free →